Leukaemia (chronic lymphocytic, relapsed) - rituximab: Appendix A - provisional matrix of stakeholders
|
Leukaemia (chronic lymphocytic, relapsed) - rituximab: Appendix A - provisional matrix of stakeholders
20 January 2014 (100.52 Kb 29 sec) |
This page was last updated: 14 January 2014